Medication for tumor-related pain - factors influencing the intake behavior of different active substances

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028517

Enrollment

Registered

2022-03-10

Start date

2022-04-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.1

Interventions

Group 1: Patients with pain from malignant tumor disease who are receiving pain medications will be interviewed about their attitude and medication-taking patterns.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult tumor patients with pain; all ages; both sexes; WHO stage I to III already in use; all dynamics of pain change; disturbed or undisturbed relationship with the practitioner.

Exclusion criteria

Exclusion criteria: Patient refusal to participate in the study, lack of consent, patients legally incapable of giving consent, insufficient understanding of the German language, patients under 18 years of age.

Design outcomes

Primary

Measure	Time frame
The aim of the study is to identify influencing factors on pain medication taking behavior. For this purpose, a qualitative analysis of patient interviews with MaxQda will be conducted.	—

Countries

Germany

Contacts

Public ContactMarco Richard Zugaj

Klinik für AnästhesiologieUniversitätsklinikum Heidelberg Sektion Schmerzmedizin

marco.zugaj@med.uni-heidelberg.de0049 6221 56 36852

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026